252 related articles for article (PubMed ID: 38628031)
1. Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S.
Mitsikostas DD; Caronna E; De Tommaso M; Deligianni CI; Ekizoglu E; Bolay H; Göbel CH; Kristoffersen ES; Lampl C; Moro E; Pozo-Rosich P; Sellner J; Terwindt G; Irimia-Sieira P
Eur J Neurol; 2024 Jul; 31(7):e16308. PubMed ID: 38628031
[No Abstract] [Full Text] [Related]
2. Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic.
Finsterer J; Mehri S
Eur J Neurol; 2024 Jul; 31(7):e16307. PubMed ID: 38623031
[No Abstract] [Full Text] [Related]
3. Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
Kamura Y; Matsue K
Int J Infect Dis; 2022 Sep; 122():1005. PubMed ID: 35760377
[No Abstract] [Full Text] [Related]
4. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.
Mitsikostas DD; Caronna E; De Tommaso M; Deligianni CI; Ekizoglu E; Bolay H; Göbel CH; Kristoffersen ES; Lampl C; Moro E; Pozo-Rosich P; Sellner J; Terwindt G; Irimia-Sieira P
Eur J Neurol; 2024 Jun; 31(6):e16251. PubMed ID: 38415282
[TBL] [Abstract][Full Text] [Related]
5. Comment on "SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer.
Galassi G
J Neuroimmunol; 2022 Aug; 369():577901. PubMed ID: 35667183
[No Abstract] [Full Text] [Related]
6. Questionnaire-based study of COVID-19 vaccination induced headache: evidence of clusters of adverse events.
Zhou Q; Eggert T; Zhelyazkova A; Choukér A; Adorjan K; Straube A
BMC Neurol; 2024 Mar; 24(1):84. PubMed ID: 38431578
[TBL] [Abstract][Full Text] [Related]
7. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study.
Sekiguchi K; Watanabe N; Miyazaki N; Ishizuchi K; Iba C; Tagashira Y; Uno S; Shibata M; Hasegawa N; Takemura R; Nakahara J; Takizawa T
Cephalalgia; 2022 Mar; 42(3):266-272. PubMed ID: 34407651
[TBL] [Abstract][Full Text] [Related]
8. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
Jain E; Donowitz JR; Aarons E; Marshall BC; Miller MP
Emerg Infect Dis; 2022 May; 28(5):990-993. PubMed ID: 35275051
[TBL] [Abstract][Full Text] [Related]
9. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes.
Finsterer J
Muscle Nerve; 2022 Jun; 65(6):E31-E32. PubMed ID: 35385125
[No Abstract] [Full Text] [Related]
10. Vaccine-Induced Immune Thrombotic Thrombocytopenia with Concurrent Arterial and Venous Thrombi Following Ad26.COV2.S Vaccination.
Charidimou A; Samudrala S; Cervantes-Arslanian AM; Sloan JM; Dasenbrock HH; Daneshmand A
J Stroke Cerebrovasc Dis; 2021 Dec; 30(12):106113. PubMed ID: 34547677
[No Abstract] [Full Text] [Related]
11. Multisystem inflammatory syndrome after SARS-CoV-2 vaccination (MIS-V), to interpret with caution.
Iyengar KP; Nune A; Ish P; Botchu R; Shashidhara MK; Jain VK
Postgrad Med J; 2022 Mar; 98(e2):e91. PubMed ID: 37066534
[No Abstract] [Full Text] [Related]
12. Lichen Ruber Planus occurring after SARS-CoV-2 vaccination.
Zengarini C; Piraccini BM; La Placa M
Dermatol Ther; 2022 May; 35(5):e15389. PubMed ID: 35174595
[No Abstract] [Full Text] [Related]
13. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.
Poizeau F; Triquet L; Dupuy A
Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360
[No Abstract] [Full Text] [Related]
14. Sarcoidal immune reaction following SARS-CoV-2 vaccination.
Abu Rached N; Mansour R; Susok L; Fried S; Abolmaali N; Lee YP; Gambichler T
Clin Exp Dermatol; 2022 May; 47(5):970-972. PubMed ID: 34978352
[TBL] [Abstract][Full Text] [Related]
15. Reply to "The nature and severity of SARS-CoV-2 vaccines side effects are highly dependent on study design" and "Self-reported side effects following COVID-19 vaccination in athletes: Correspondence".
Komici K; Verderosa S; D'Amico F; Guerra G
Hum Vaccin Immunother; 2023 Aug; 19(2):2260534. PubMed ID: 37737129
[No Abstract] [Full Text] [Related]
16. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.
Castaldo M; Waliszewska-Prosół M; Koutsokera M; Robotti M; Straburzyński M; Apostolakopoulou L; Capizzi M; Çibuku O; Ambat FDF; Frattale I; Gadzhieva Z; Gallo E; Gryglas-Dworak A; Halili G; Jusupova A; Koperskaya Y; Leheste AR; Manzo ML; Marcinnò A; Marino A; Mikulenka P; Ong BE; Polat B; Popovic Z; Rivera-Mancilla E; Roceanu AM; Rollo E; Romozzi M; Ruscitto C; Scotto di Clemente F; Strauss S; Taranta V; Terhart M; Tychenko I; Vigneri S; Misiak B; Martelletti P; Raggi A;
J Headache Pain; 2022 Mar; 23(1):41. PubMed ID: 35361131
[TBL] [Abstract][Full Text] [Related]
17. Accruing real-world data confirm that SARS-CoV-2 vaccination is not associated with stroke.
Palaiodimou L
J Neurol Sci; 2024 Jan; 456():120850. PubMed ID: 37923646
[No Abstract] [Full Text] [Related]
18. Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer.
Maranini B; Ciancio G; Cultrera R; Govoni M
Reumatismo; 2022 May; 74(1):. PubMed ID: 35506316
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.
Afshar ZM; Barary M; Babazadeh A; Hosseinzadeh R; Alijanpour A; Miri SR; Sio TT; Sullman MJM; Carson-Chahhoud K; Langer F; Ebrahimpour S
Rev Med Virol; 2022 Jul; 32(4):e2327. PubMed ID: 35112763
[TBL] [Abstract][Full Text] [Related]
20. Two cases with new onset of pemphigus foliaceus after SARS-CoV-2 vaccination.
Rouatbi J; Aounallah A; Lahouel M; Sriha B; Belajouza C; Denguezli M
Dermatol Ther; 2022 Nov; 35(11):e15827. PubMed ID: 36111460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
